Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Latest, Q2 2026
6,207
Period ended Jun 30, 2026
Change on a year earlier
-6.0%
6,601 in Q2 2025
History
68 quarters
Since Q4 2008
Sources
66
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Inventories ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 6,207 | -6.0% | Form 10-Q (filed 2026-08-07) ↗ |
| Q1 2026 | Mar 31, 2026 | 6,479 | +4.6% | Form 10-Q (filed 2026-05-04) ↗ |
| Q4 2025 | Dec 31, 2025 | 6,658 | +9.0% | Form 10-K (filed 2026-02-24) ↗ |
| Q3 2025 | Sep 30, 2025 | 6,444 | +3.2% | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2025 | Jun 30, 2025 | 6,601 | +2.0% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 6,196 | -4.8% | Form 10-Q (filed 2025-05-02) ↗ |
| Q4 2024 | Dec 31, 2024 | 6,109 | -3.9% | Form 10-K (filed 2025-02-25) ↗ |
| Q3 2024 | Sep 30, 2024 | 6,244 | +1.8% | Form 10-Q (filed 2024-11-06) ↗ |
| Q2 2024 | Jun 30, 2024 | 6,469 | +9.1% | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 6,510 | +11.0% | Form 10-Q (filed 2024-05-03) ↗ |
| Q4 2023 | Dec 31, 2023 | 6,358 | +7.6% | Form 10-K (filed 2024-02-26) ↗ |
| Q3 2023 | Sep 30, 2023 | 6,131 | +9.2% | Form 10-Q (filed 2023-11-03) ↗ |
| Q2 2023 | Jun 30, 2023 | 5,930 | +7.1% | Form 10-Q (filed 2023-08-07) ↗ |
| Q1 2023 | Mar 31, 2023 | 5,863 | +1.5% | Form 10-Q (filed 2023-05-05) ↗ |
| Q4 2022 | Dec 31, 2022 | 5,911 | -0.7% | Form 10-K (filed 2023-02-24) ↗ |
| Q3 2022 | Sep 30, 2022 | 5,614 | +0.2% | Form 10-Q (filed 2022-11-03) ↗ |
| Q2 2022 | Jun 30, 2022 | 5,535 | +0.7% | Form 10-Q (filed 2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | 5,774 | -9.8% | Form 10-Q (filed 2022-05-05) ↗ |
| Q4 2021 | Dec 31, 2021 | 5,953 | +7.2% | Form 10-K (filed 2022-02-25) ↗ |
| Q3 2021 | Sep 30, 2021 | 5,603 | -8.6% | Form 10-Q (filed 2021-11-05) ↗ |
| Q2 2021 | Jun 30, 2021 | 5,499 | -9.2% | Form 10-Q (filed 2021-08-09) ↗ |
| Q1 2021 | Mar 31, 2021 | 6,402 | +9.5% | Form 10-Q (filed 2021-05-05) ↗ |
| Q4 2020 | Dec 31, 2020 | 5,554 | -7.1% | Form 10-Q (filed 2021-08-09) ↗ |
| Q3 2020 | Sep 30, 2020 | 6,128 | +4.7% | Form 10-Q (filed 2020-11-05) ↗ |
| Q2 2020 | Jun 30, 2020 | 6,056 | +3.6% | Form 10-Q (filed 2020-08-05) ↗ |
| Q1 2020 | Mar 31, 2020 | 5,846 | +2.3% | Form 10-Q (filed 2020-05-06) ↗ |
| Q4 2019 | Dec 31, 2019 | 5,978 | +9.9% | Form 10-K (filed 2020-02-26) ↗ |
| Q3 2019 | Sep 30, 2019 | 5,855 | +8.1% | Form 10-Q (filed 2019-11-05) ↗ |
| Q2 2019 | Jun 30, 2019 | 5,847 | +12.9% | Form 10-Q (filed 2019-08-06) ↗ |
| Q1 2019 | Mar 31, 2019 | 5,712 | +6.1% | Form 10-Q (filed 2019-05-08) ↗ |
| Q4 2018 | Dec 31, 2018 | 5,440 | +6.8% | Form 10-K (filed 2019-02-27) ↗ |
| Q3 2018 | Sep 30, 2018 | 5,416 | +2.9% | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2018 | Jun 30, 2018 | 5,178 | -4.2% | Form 10-Q (filed 2018-08-07) ↗ |
| Q1 2018 | Mar 31, 2018 | 5,382 | +4.6% | Form 10-Q (filed 2018-05-08) ↗ |
| Q4 2017 | Dec 31, 2017 | 5,096 | +4.7% | Form 10-K (filed 2018-02-27) ↗ |
| Q3 2017 | Sep 30, 2017 | 5,263 | +0.4% | SEC Filing ↗ |
| Q2 2017 | Jun 30, 2017 | 5,407 | +3.0% | SEC Filing ↗ |
| Q1 2017 | Mar 31, 2017 | 5,146 | +0.9% | SEC Filing ↗ |
| Q4 2016 | Dec 31, 2016 | 4,866 | +3.5% | SEC Filing ↗ |
| Q3 2016 | Sep 30, 2016 | 5,244 | +2.4% | SEC Filing ↗ |
| Q2 2016 | Jun 30, 2016 | 5,248 | -1.1% | SEC Filing ↗ |
| Q1 2016 | Mar 31, 2016 | 5,102 | -7.9% | SEC Filing ↗ |
| Q4 2015 | Dec 31, 2015 | 4,700 | -15.6% | Form 10-K (filed 2016-02-26) ↗ |
| Q3 2015 | Sep 30, 2015 | 5,123 | -12.0% | Form 10-Q (filed 2015-11-05) ↗ |
| Q2 2015 | Jun 30, 2015 | 5,306 | -13.5% | Form 10-Q (filed 2015-08-06) ↗ |
| Q1 2015 | Mar 31, 2015 | 5,539 | -13.1% | Form 10-Q (filed 2015-05-07) ↗ |
| Q4 2014 | Dec 31, 2014 | 5,571 | -10.5% | Form 10-K (filed 2015-02-27) ↗ |
| Q3 2014 | Sep 30, 2014 | 5,819 | -13.7% | Form 10-Q (filed 2014-11-10) ↗ |
| Q2 2014 | Jun 30, 2014 | 6,136 | – | Form 10-Q (filed 2014-08-07) ↗ |
| Q1 2014 | Mar 31, 2014 | 6,376 | -5.9% | Form 10-Q (filed 2014-05-08) ↗ |
| Q4 2013 | Dec 31, 2013 | 6,226 | -4.7% | Form 10-K (filed 2014-02-27) ↗ |
| Q2 2013 | Sep 30, 2013 | 6,741 | +0.1% | Form 10-Q (filed 2013-11-07) ↗ |
| Q1 2013 | Mar 31, 2013 | 6,773 | +6.8% | Form 10-Q (filed 2013-05-09) ↗ |
| Q4 2012 | Dec 31, 2012 | 6,535 | +4.5% | Form 10-K (filed 2013-02-28) ↗ |
| Q3 2012 | Sep 30, 2012 | 6,731 | +7.9% | Form 10-Q (filed 2012-11-09) ↗ |
| Q2 2012 | Jun 30, 2012 | 6,249 | +0.4% | Form 10-Q (filed 2012-08-07) ↗ |
| Q1 2012 | Mar 31, 2012 | 6,339 | – | Form 10-Q (filed 2012-05-08) ↗ |
| Q4 2011 | Dec 31, 2011 | 6,254 | +6.6% | Form 10-K (filed 2012-02-28) ↗ |
| Q3 2011 | Sep 30, 2011 | 6,239 | -0.4% | Form 10-Q (filed 2011-11-08) ↗ |
| Q2 2011 | Jun 30, 2011 | 6,225 | -0.3% | Form 10-Q (filed 2011-08-08) ↗ |
| Q4 2010 | Dec 31, 2010 | 5,868 | -27.1% | Form 10-K (filed 2011-02-28) ↗ |
| Q3 2010 | Sep 30, 2010 | 6,264 | +81.1% | Form 10-Q (filed 2010-11-08) ↗ |
| Q2 2010 | Jun 30, 2010 | 6,244 | +79.5% | Form 10-Q (filed 2010-08-06) ↗ |
| Q1 2010 | Mar 31, 2010 | 6,825 | – | Form 10-Q (filed 2010-05-07) ↗ |
| Q4 2009 | Dec 31, 2009 | 8,048 | +284.9% | Form 10-K (filed 2011-02-28) ↗ |
| Q3 2009 | Sep 30, 2009 | 3,459 | – | Form 10-Q (filed 2009-10-29) ↗ |
| Q2 2009 | Jun 30, 2009 | 3,478 | – | Form 10-Q (filed 2009-07-24) ↗ |
| Q4 2008 | Dec 31, 2008 | 2,091 | – | Form 10-K (filed 2010-03-01) ↗ |
Cite this data
StockData. (2026). Merck Inventories ($M) ($M), quarterly Q4 2008–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_bal_inv
See every metric in the Merck KPI table. Data updated Oct 26, 2026.